Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
UNC13C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PHF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAB11FIP3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GPRIN3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IGK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
GSTP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SEPSECS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ERO1B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BEX3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRAF3IP3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ITGB5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SYNJ2BP-COX16 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TTC39C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANXA6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC339166 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ETS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SDAD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PARVB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on